Bharat Parenterals Share Price: Loss kam, Pharma Export ka Rasta khula! Dividend bhi pakka!

OTHER
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Bharat Parenterals Share Price: Loss kam, Pharma Export ka Rasta khula! Dividend bhi pakka!
Overview

Bhai log, Bharat Parenterals ne FY26 ke results announce kar diye hain. Good news yeh hai ki company ka loss kam ho gaya hai, matlab woh profit ki taraf badh rahi hai. Aur toh aur, unki ek subsidiary ko US aur Europe mein business karne ki permission mil gayi hai! Plus, dividend bhi mil raha hai shareholders ko.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Toh suno, Bharat Parenterals ne FY26 mein apna Net Loss ₹43.68 Crore se kam karke sirf ₹27.31 Crore kar liya hai. Revenue thoda sa neeche aaya hai, ₹345.43 Crore raha FY26 mein, FY25 ke ₹352 Crore ke comparison mein. Par loss kam hona is a big deal, matlab company cheezein sahi kar rahi hai.

Ab sabse zabardast khabar yeh hai ki unki jo subsidiaries hain, khaas kar Innoxel Lifesciences, usko USFDA se EIR (Establishment Inspection Report) mil gaya hai aur EU-GMP certification bhi. Iska matlab hai ki yeh US aur Europe jaise bade aur regulated markets mein apna maal bech payenge. Yeh ekdum game changer ho sakta hai bhai! Aur ek aur subsidiary, Varenyam Healthcare, woh bhi wapas profit mein aa gayi hai.

Shareholders ke liye bhi good news hai. Board ne ₹1.00 per equity share ka final dividend recommend kiya hai. Woh bhi apni earnings call mein bata rahe hain ki FY27 mein commercial growth unke liye bahut important hone wali hai.

Company ne apni facilities upgrade ki hain aur global standards follow kar rahi hai. Innoxel Lifesciences FY27 ke Q2 tak apna pehla commercial supply start karne ka plan kar rahi hai. Toh overall, Bharat Parenterals aage badhne ki koshish mein hai.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.